Below are the most recent publications written about "Cognitive Dysfunction" by people in Profiles.
-
Rovner BW, Casten RJ. Discordant Medication Beliefs in Black Individuals With Mild Cognitive Impairment and Diabetes. Am J Geriatr Psychiatry. 2025 04; 33(4):337-341.
-
Zhang Q, Hudgins S, Struck AF, Ankeeta A, Javidi SS, Sperling MR, Hermann BP, Tracy JI. Association of Normative and Non-Normative Brain Networks With Cognitive Function in Patients With Temporal Lobe Epilepsy. Neurology. 2024 Oct 08; 103(7):e209800.
-
Fairchild JK, Myers J, Louras P, Jo B, McNerney MW, Hallmayer J, Yesavage J. Multimodal Exercise and Cognitive Training Program Improves Cognitive Function in Amnestic Mild Cognitive Impairment. Am J Geriatr Psychiatry. 2024 04; 32(4):463-474.
-
El-Sabawi B, Cloud H, Patel JN, Bell SP, Elmariah S, Fearon WF, Kim JB, Piana RN, Kapadia SR, Kumbhani DJ, Gillam LD, Whisenant BK, Quader N, Zajarias A, Welt FG, Bavry AA, Coylewright M, Vatterott A, Jackson N, Huang S, Lindman BR. Association of Depression and Cognitive Dysfunction With Patient-Centered Outcomes After Transcatheter Aortic Valve Replacement. Circ Cardiovasc Interv. 2023 08; 16(8):e012875.
-
Delgorio PL, Hiscox LV, McIlvain G, Kramer MK, Diano AM, Twohy KE, Merritt AA, McGarry MDJ, Schwarb H, Daugherty AM, Ellison JM, Lanzi AM, Cohen ML, Martens CR, Johnson CL. Hippocampal subfield viscoelasticity in amnestic mild cognitive impairment evaluated with MR elastography. Neuroimage Clin. 2023; 37:103327.
-
Casten R, Leiby BE, Kelley M, Rovner BW. A randomized controlled trial to test the efficacy of a diabetes behavioral intervention to prevent memory decline in older blacks/African Americans with diabetes and mild cognitive impairment. Contemp Clin Trials. 2022 12; 123:106977.
-
Chen PC, Han X, Shaw TI, Fu Y, Sun H, Niu M, Wang Z, Jiao Y, Teubner BJW, Eddins D, Beloate LN, Bai B, Mertz J, Li Y, Cho JH, Wang X, Wu Z, Liu D, Poudel S, Yuan ZF, Mancieri A, Low J, Lee HM, Patton MH, Earls LR, Stewart E, Vogel P, Hui Y, Wan S, Bennett DA, Serrano GE, Beach TG, Dyer MA, Smeyne RJ, Moldoveanu T, Chen T, Wu G, Zakharenko SS, Yu G, Peng J. Alzheimer's disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment. Nat Aging. 2022 10; 2(10):923-940.
-
Cohen JB, Marcum ZA, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Scharfstein D, Williamson J, Pajewski NM, Bress AP. Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT). JAMA Netw Open. 2022 07 01; 5(7):e2220680.
-
Early ML, Linton E, Bosch A, Campbell T, Hill-Briggs F, Pecker LH, Lance EI, Lanzkron S. The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains. Br J Haematol. 2022 07; 198(2):382-390.
-
Marcum ZA, Cohen JB, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Williamson J, Pajewski NM, Bress AP. Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment. JAMA Netw Open. 2022 01 04; 5(1):e2145319.